ClinicalTrials.Veeva

Menu

Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention (FACTPCI)

The Guthrie Clinic logo

The Guthrie Clinic

Status and phase

Terminated
Phase 4

Conditions

Percutaneous Coronary Intervention

Treatments

Drug: Fentanyl
Drug: Ticagrelor 90Mg Tablet

Study type

Interventional

Funder types

Other

Identifiers

NCT03476369
1801-05

Details and patient eligibility

About

During a percutaneous coronary intervention (PCI), Fentanyl is commonly used for sedation. Ticagrelor is also routinely used as anti-platelet agent during PCI. However, a recent study has demonstrated the decrease in effectiveness of Ticagrelor when administered along with Fentanyl. Hence this study was designed to further assess the interaction between crushed vs non crushed Ticagrelor and Fentanyl given during PCI procedures.

Enrollment

45 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Undergoing clinically indicated elective or non-elective PCI
  • Able to swallow oral medications

Exclusion criteria

  • Contraindications to ticagrelor or fentanyl (or other opiates)
  • Pregnancy
  • Any use of P2Y12 inhibitors within 14 days
  • Known coagulation disorders
  • Pre-procedural treatment with an anticoagulant (oral anticoagulant or low molecular weight heparin)
  • Platelet count < 100,000/mm3
  • Impaired renal function (Estimated glomerular filtration < 45 ml/min/1.73 m2)
  • Impaired hepatic function (Based on medical history)
  • Prior or planned transcatheter aortic valve replacement

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

45 participants in 2 patient groups

Fentanyl and Crushed Ticagrelor
Experimental group
Description:
Premedicated with Fentanyl (at least 25mcg by IV) followed by Ticagrelor 90mg tablet administered crushed (180 mg dose)
Treatment:
Drug: Ticagrelor 90Mg Tablet
Drug: Fentanyl
Fentanyl and Non-crushed Ticagrelor
Active Comparator group
Description:
Premedicated with Fentanyl (at least 25mcg by IV) followed by Ticagrelor 90mg tablet administered as a whole tablet (180 mg dose)
Treatment:
Drug: Ticagrelor 90Mg Tablet
Drug: Fentanyl

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Sudhakar Sattur, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems